BioNote, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported negative sales was KRW 0.00039 million compared to sales of KRW 0.00032 million a year ago. Net loss was KRW 22,757.19 million compared to net income of KRW 249,315.27 million a year ago.

Basic loss per share from continuing operations was KRW 223 compared to basic earnings per share from continuing operations of KRW 2,665 a year ago. Basic loss per share was KRW 223 compared to basic earnings per share of KRW 2,665 a year ago.